🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Germ-Line Mutations in Blood and Saliva Samples From Patients With Cancer

Recruitingn/aAges 18 Years - anyAllJonsson Comprehensive Cancer Center
NCT02280161 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This research trial studies germ-line mutations in blood and saliva samples from patients with cancer. Studying samples of blood and saliva from patients with cancer in the laboratory may help doctors learn more about how inherited genetic mutations can affect cancer predisposition (an inherited increase in the risk of developing cancer), their impact on treatment response, and their role in cancer development.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Pathologically or clinical confirmed tissue diagnosis of a cancer * Ability to understand and the willingness to sign a written informed consent Exclusion Criteria: * Patients will be excluded if their cancer cannot be confirmed * Refusal to sign the informed consent
💊

What it tests

  • cytology specimen collection procedure
📍

Where

1 site
Jonsson Comprehensive Cancer Center
Los Angeles, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy